BTCS CFO Granted 81,613 Options at $4.20 — Form 4 Disclosure
Michael E. Prevoznik Jr., identified as the Chief Financial Officer of BTCS Inc. (BTCS), was granted 81,613 stock options on 08/07/2025 with an exercise price of $4.20 per share.
Rhea-AI Filing Summary
Michael E. Prevoznik Jr., identified as the Chief Financial Officer of BTCS Inc. (BTCS), was granted 81,613 stock options on 08/07/2025 with an exercise price of $4.20 per share. The filing classifies these as derivative securities and reports 81,613 underlying common shares as beneficially owned following the grant. The options vest on December 31, 2026, subject to continued employment on that date, and the document lists 08/07/2032 in the date column associated with the award. The Form 4 was signed and dated 08/08/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine compensatory option grant to the CFO; vesting is employment-contingent and the grant is disclosed as direct ownership.
The Form 4 documents a standard executive equity award: 81,613 options at an exercise price of $4.20 granted on 08/07/2025. Vesting is explicitly tied to continued employment through 12/31/2026, which aligns executive pay with tenure. The filing lists the position (CFO) and reports direct beneficial ownership following the grant. This disclosure follows Section 16 reporting norms and provides transparency on potential dilution and insider alignment.
TL;DR: The grant is a time‑based option award with a multi‑year vest and a stated exercise price, consistent with standard incentive design.
The awarded instrument is a stock option (derivative) for 81,613 shares at $4.20 per share, dated 08/07/2025. The explicit vesting date of 12/31/2026 conditions payout on continued employment. An expiration/associated date of 08/07/2032 is listed in the filing. As reported, ownership after the transaction equals the number of underlying shares, indicating this is a newly granted compensatory instrument rather than a disposition.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 81,613 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock options vest on December 31, 2026, subject to continued employment with the Company on the vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BTCS (BTCS) report by the CFO on 08/07/2025?
What is the exercise price and vesting schedule for the BTCS option grant?
When was the Form 4 signed and filed for the BTCS transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.